Similar articles

• Pharmaceuticals issue brief: generic and therapeutic substitution: year end report--2004.

  Health Policy Tracking Service staff. Health Policy Tracking Service staff. Issue Brief Health Policy Track Serv. 2004 Dec 31:1-14. Issue Brief Health Policy Track Serv. 2004. PMID: 15724310 No abstract available.
• Pharmaceuticals: Medicaid drug cost containment: year end report-2002.

  Floridi T, Kammer C. Floridi T, et al. Issue Brief Health Policy Track Serv. 2002 Dec 31:1-13. Issue Brief Health Policy Track Serv. 2002. PMID: 12856684 No abstract available.
• Pharmaceuticals issue brief: pharmaceuticals cost control: year end report--2004.

  Seay M. Seay M. Issue Brief Health Policy Track Serv. 2004 Dec 31:1-17. Issue Brief Health Policy Track Serv. 2004. PMID: 15724308 No abstract available.
• Current approaches to the use of generic antiepileptic drugs.

  Krämer G, Biraben A, Carreno M, Guekht A, de Haan GJ, Jedrzejczak J, Josephs D, van Rijckevorsel K, Zaccara G. Krämer G, et al. Epilepsy Behav. 2007 Aug;11(1):46-52. doi: 10.1016/j.yebeh.2007.03.014. Epub 2007 May 29. Epilepsy Behav. 2007. PMID: 17537678 Review.
• ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: a report of the American College of Cardiology Foundation Clinical Quality Committee.

  Holmes DR Jr, Becker JA, Granger CB, Limacher MC, Page RL 2nd, Sila C; American College of Cardiology Foundation Clinical Quality Committee. Holmes DR Jr, et al. J Am Coll Cardiol. 2011 Sep 13;58(12):1287-307. doi: 10.1016/j.jacc.2011.06.001. Epub 2011 Aug 16. J Am Coll Cardiol. 2011. PMID: 21849242 No abstract available.